Agios Pharmaceuticals
AGIO
AGIO
217 hedge funds and large institutions have $4.54B invested in Agios Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 83 increasing their positions, 61 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $4.49B → $4.54B (+$51.4M)
1.33% less ownership
Funds ownership: 95.79% → 94.46% (-1.3%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
217
Holding in Top 10
4
Calls
$46.9M
Puts
$33M
Top Buyers
| 1 | +$32.8M | |
| 2 | +$28.2M | |
| 3 | +$13.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.9M |
| 5 |
Goldman Sachs
New York
|
+$8.79M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$23.3M | |
| 3 | -$21.1M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$20.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.1M |